A Practical Radiosynthesis of ( S )‐[ 11 C]SMBT‐1 for MAO‐B PET Imaging
Journal of Labelled Compounds and Radiopharmaceuticals · 2026
DOI: 10.1002/jlcr.70037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2026. Verfasst von Hari K Akula und 9 weiteren Autor:innen. Beteiligte Einrichtung: PET Research Core, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Monoamine Oxidase, Carbon Radioisotopes, Radiopharmaceuticals. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NIH HHS, Stony Brook University.
Abstract (Originalsprache)
Monoamine oxidase B (MAO‐B) is highly expressed in reactive astrocytes and is implicated in multiple neurodegenerative and neuropsychiatric conditions, making it an important PET imaging target. Building on the promising PET imaging properties of ( S )‐(2‐methylpyrid‐5‐yl)‐6‐[(3‐ 18 F‐fluoro‐2‐hydroxy)propoxy]quinoline (( S )‐[ 18 F]SMBT‐1), we developed a carbon‐11‐labeled analog, ( S )‐(2‐ 11 C‐methylpyrid‐5‐yl)‐6‐[(3‐fluoro‐2‐hydroxy)propoxy]quinoline (( S )‐[ 11 C]SMBT‐1). The short half‐life of carbon‐11 (t 1/2 = 20.7 min) enables same‐day, repeat scans and pharmacological challenge studies within the same subject. An efficient radiosynthesis of ( S )‐[ 11 C]SMBT‐1 was developed via palladium‐mediated Stille cross‐coupling followed by acid deprotection. The radiosynthesis was completed within 28.4 ± 0.9 min from end of bombardment (EOB) ( n = 3), providing ( S )‐[ 11 C]SMBT‐1 in 11.9% ± 2.7% radiochemical yield (decay‐corrected) with final product activity of 1.76 ± 0.28 GBq (47.4 ± 7.5 mCi) and molar activity of 58.8 ± 8.0 GBq/μmol (1.59 ± 0.22 Ci/μmol) at end of synthesis (EOS), high radiochemical purity (> 99%) and enantiomeric excess (> 99%). The developed radiosynthetic method provides reliable access to ( S )‐[ 11 C]SMBT‐1, and in vivo evaluation studies are currently underway to further assess its potential for future clinical MAO‐B PET imaging applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PET Research Core, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Department of Psychiatry and Behavioral Health, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
- Department of Chemistry, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
- Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
- Research Center for Accelerator and Radioisotope Science, Tohoku University, Sendai, Japan.
- Department of Neurology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
ORCID-Profile: Ryuichi Harada, Shozo Furumoto, Nobuyuki Okamura, Bao Hu
Förderung
- NIBIB NIH HHS
- NIH HHS
- Stony Brook University
- Stony Brook Medicine
- National Institutes of Health
Zitieren
APA
Akula, H. K., Pati, S., Qu, W., Slifstein, M., Parsey, R., Harada, R., Furumoto, S., Okamura, N., Kim, M. J., & Hu, B. (2026). A Practical Radiosynthesis of ( S )‐[ 11 C]SMBT‐1 for MAO‐B PET Imaging. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.70037
Vancouver
Akula HK, Pati S, Qu W, Slifstein M, Parsey R, Harada R, et al. A Practical Radiosynthesis of ( S )‐[ 11 C]SMBT‐1 for MAO‐B PET Imaging. Journal of Labelled Compounds and Radiopharmaceuticals. 2026. doi:10.1002/jlcr.70037
BibTeX
@article{Akula2026,
author = {Akula, Hari K and Pati, Soumyaranjan and Qu, Wenchao and Slifstein, Mark and Parsey, Ramin and Harada, Ryuichi and Furumoto, Shozo and Okamura, Nobuyuki and Kim, Min-Jeong and Hu, Bao},
title = {A Practical Radiosynthesis of ( S )‐[ 11 C]SMBT‐1 for MAO‐B PET Imaging},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2026},
doi = {10.1002/jlcr.70037}
}
EUVIMED